Abstract
Levels of CA 125, determined in three patients with ovarian carcinoma undergoing autologous bone marrow transplantation, dropped significantly in the month after bone marrow transplantation. This decrease was linear by multiple regression analysis. The CA 125 decrease after bone marrow transplantation in patients with nonevaluable or stable disease may represent biologic response to high-dose therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 354-355 |
| Number of pages | 2 |
| Journal | American journal of obstetrics and gynecology |
| Volume | 160 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1989 |
| Externally published | Yes |
Keywords
- CA 125
- bone marrow transplantation
- ovarian carcinoma
ASJC Scopus subject areas
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS